Covered recipient · General Payments record
LINDA S HUSER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$1,136.16
- Reported across 65 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $457.35 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $136.63 | 9 |
| Novo Nordisk AS | $100.72 | 5 |
| Acerta Pharma LLC | $54.84 | 3 |
| Amgen Inc. | $40.89 | 2 |
| PFIZER INC. | $40.71 | 2 |
| Astellas Pharma US Inc | $19.28 | 1 |
| Exact Sciences Corporation | $18.09 | 1 |
| Lilly USA, LLC | $17.93 | 1 |
| Esperion Therapeutics, Inc. | $15.12 | 1 |
| Dynavax Technologies Corporation | $13.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $4.06 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107376424 | CMS |
| ABBVIE INC. | $15.59 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107376426 | CMS |
| ABBVIE INC. | $12.69 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107376428 | CMS |
| ABBVIE INC. | $23.78 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107376430 | CMS |
| ABBVIE INC. | $24.04 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107376432 | CMS |
| ABBVIE INC. | $9.91 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107376434 | CMS |
| ABBVIE INC. | $28.25 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107376436 | CMS |
| ABBVIE INC. | $9.56 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107376438 | CMS |
| ABBVIE INC. | $8.75 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107376440 | CMS |
| Amgen Inc. | $16.94 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117584702 | CMS |
| Amgen Inc. | $23.95 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117283377 | CMS |
| Astellas Pharma US Inc | $19.28 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139484728 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.55 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104688772 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.29 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105605659 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.00 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104639357 | CMS |
| Dynavax Technologies Corporation | $13.14 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082150361 | CMS |
| Esperion Therapeutics, Inc. | $15.12 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129468986 | CMS |
| Exact Sciences Corporation | $18.09 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114554354 | CMS |
| Lilly USA, LLC | $17.93 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135815362 | CMS |
| Novo Nordisk Inc | $18.97 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100331738 | CMS |
| Novo Nordisk Inc | $20.97 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100553413 | CMS |
| Novo Nordisk Inc | $23.69 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100632599 | CMS |
| Novo Nordisk Inc | $21.80 | 06/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100383375 | CMS |
| Novo Nordisk Inc | $15.29 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100263810 | CMS |
| PFIZER INC. | $21.88 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131587004 | CMS |
| PFIZER INC. | $18.83 | 07/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131742174 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.